Dissecting the biology of gliomagenesis: Evaluating the interaction between IDH tumor mutation and germline variants.

Saved in:
Bibliographic Details
Title: Dissecting the biology of gliomagenesis: Evaluating the interaction between IDH tumor mutation and germline variants.
Authors: Kosel ML; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Decker PA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Kollmeyer TM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Drucker KL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Shurtz AK; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Molinaro AM; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Conte GM; Department of Radiology, Mayo Clinic, Rochester, MN, USA., Moassefi M; Department of Radiology, Mayo Clinic, Rochester, MN, USA., Erickson BJ; Department of Radiology, Mayo Clinic, Rochester, MN, USA., Wiencke JK; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Francis S; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Burns TC; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA., Vaubel RA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Wrensch M; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Lachance DH; Department of Neurology, Mayo Clinic, Rochester, MN, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Tobin WO; Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.; Department of Neurology, Mayo Clinic, Rochester, MN, USA., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Eckel-Passow JE; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2025 Jul 08; Vol. 7 (1), pp. vdaf147. Date of Electronic Publication: 2025 Jul 08 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2632-2498
DOI:10.1093/noajnl/vdaf147